Aarti Pharmalabs Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. This confirmation was received from MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent. The certificate confirms that securities received from depository participants for dematerialisation during the quarter were processed and confirmed to the depositories. It also states that the securities have been listed on the stock exchanges where the company's existing securities are already listed. Furthermore, the registrar confirmed that the received security certificates were either confirmed or rejected, and subsequently mutilated and cancelled after verification. The name of the depositories has been substituted as the registered owner in the company's register of members within the stipulated timelines. The company secretary and legal head, Jeevan Mondkar, submitted this certificate to the BSE Ltd. and the National Stock Exchange of India Limited.
